Greenwich LifeSciences Inc. (GLSI) News
Filter GLSI News Items
GLSI News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
GLSI News Highlights
- For GLSI, its 30 day story count is now at 2.
- Over the past 20 days, the trend for GLSI's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about GLSI are NOV and PRE.
Latest GLSI News From Around the Web
Below are the latest news stories about GREENWICH LIFESCIENCES INC that investors may wish to consider to help them evaluate GLSI as an investment opportunity.
Insiders hold 54% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI), and they've been buying recentlyKey Insights Greenwich LifeSciences' significant insider ownership suggests inherent interests in company's expansion... |
Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024STAFFORD, Texas, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced that its Board of Directors has extended the lock-up of the shares owned by the Company’s directors, officers, and existing pre-IPO investors to December 31, 2024 which is approximatel |
Greenwich LifeSciences Insiders Added US$653.7k Of Stock To Their HoldingsGenerally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying... |
Insider Buying: Snehal Patel Acquires 1,000 Shares of Greenwich LifeSciences IncOn September 11, 2023, Snehal Patel, the CEO, CFO, and 10% Owner of Greenwich LifeSciences Inc (NASDAQ:GLSI), purchased 1,000 shares of the company. |
We Think Greenwich LifeSciences (NASDAQ:GLSI) Can Afford To Drive Business GrowthJust because a business does not make any money, does not mean that the stock will go down. For example, although... |
Insiders own 39% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) shares but retail investors control 42% of the companyKey Insights Significant control over Greenwich LifeSciences by retail investors implies that the general public has... |
Companies Like Greenwich LifeSciences (NASDAQ:GLSI) Are In A Position To Invest In GrowthThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com... |
Insider Buying: The Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO, CFO & Director Just Bought US$61k Worth Of SharesEven if it's not a huge purchase, we think it was good to see that Snehal Patel, the CEO, CFO & Director of Greenwich... |
Greenwich LifeSciences Provides Year End UpdateSTAFFORD, Texas, December 29, 2022--Greenwich LifeSciences Provides Year End Update |
After Golden Cross, Greenwich LifeSciences, Inc. (GLSI)'s Technical Outlook is BrightShould investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average? |